Is probiotic prophylaxis worthwhile in patients with predicted severe acute pancreatitis?

Nature Clinical Practice Gastroenterology and Hepatology

Volumn 5, Issue 11, 2008, Pages 602-603

  Bengmark, Stig ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; INTERLEUKIN 10; PLACEBO; PREBIOTIC AGENT; PROBIOTIC AGENT; PROSTAGLANDIN E2; TRANSFORMING GROWTH FACTOR BETA;

ACUTE PANCREATITIS; ANTIGENIC MODULATION; ANTIINFLAMMATORY ACTIVITY; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM BIFIDUM; CD4+ T LYMPHOCYTE; CELL ACTIVITY; CLINICAL TRIAL; CYTOKINE RELEASE; DRUG EFFICACY; ENZYME INHIBITION; HUMAN; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LACTOBACILLUS DELBRUECKII; LACTOBACILLUS PARACASEI; LACTOBACILLUS PLANTARUM; LACTOBACILLUS SALIVARIUS; MORTALITY; NOTE; PRIORITY JOURNAL; PROPHYLAXIS; TRICHINOSIS;

EID: 55749099806     PISSN: 17434378     EISSN: 17434386     Source Type: Journal    
DOI: 10.1038/ncpgasthep1260     Document Type: Note

References (7)

1. Frossard JL et al. (2008) Acute pancreatitis. Lancet 371 143-152
2. Oláh A et al. (2002) Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis. Br J Surg 89: 1103-1107
3. Oláh A et al. (2007) Synbiotic control of inflammation and infection in severe acute pancreatitis: A prospective, randomized, double blind study. Hepatogastroenterology 54: 590-594
4. Besselink MG et al. (2008) Probiotic prophylaxis in predicted severe acute pancreatitis: A randomised, double-blind, placebo-controlled trial. Lancet 371: 651-659
5. Sand J and Nordback I (2008) Probiotics in severe acute pancreatitis. Lancet 371: 634-635
6. Bengmark S: Bio-ecological control of chronic liver disease and encephalopathy. Metab Brain Dis, in press
7. Bengmark S (2006) Bioecologic control of inflammation and infection in critical illness. Anesthesiol Clin 24: 299-323